STOK · Stoke Therapeutics, Inc. · Documents
$26.74
+0.13 (+0.49%)
At close · Oct 21
Return incl. dividend (before tax)
Market Cap
$1.72B
Shares
64.53M
Volume · Oct 20
2.46M
Avg daily vol (3M)
903.63K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-05-06 | — | |
| 10-Q | — | 2024-05-06 | 2024-03-31 | |
| 8-K | — | 2024-04-29 | — | |
| DEFA14A | — | 2024-04-23 | — | |
| DEF 14A | — | 2024-04-23 | 2024-06-05 | |
| 8-K | — | 2024-03-28 | 2024-03-27 | |
| 8-K | — | 2024-03-25 | — | |
| 10-K | — | 2024-03-25 | 2023-12-31 | |
| 8-K | — | 2024-03-25 | — | |
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2023-12-14 | 2023-12-12 | |
| SC TO-I/A | — | 2023-12-05 | — | |
| 8-K | — | 2023-12-01 | — | |
| SC TO-I/A | — | 2023-11-17 | — | |
| SC TO-I/A | — | 2023-11-09 | — | |
| 10-Q | — | 2023-11-07 | 2023-09-30 | |
| 8-K | — | 2023-11-07 | — | |
| SC TO-I | — | 2023-11-02 | — | |
| 8-K | — | 2023-10-26 | 2023-10-24 | |
| DEF 14A | — | 2023-09-28 | 2023-10-24 | |
| 8-K | — | 2023-09-20 | 2023-09-19 | |
| PRE 14A | — | 2023-09-18 | 2023-09-15 | |
| 8-K | — | 2023-08-07 | — | |
| 10-Q | — | 2023-08-07 | 2023-06-30 | |
| 8-K | — | 2023-07-25 | — | |
| 8-K | — | 2023-06-20 | 2023-06-13 | |
| DEFA14A | — | 2023-05-24 | — | |
| 10-Q | — | 2023-05-04 | 2023-03-31 | |
| 8-K | — | 2023-05-04 | — | |
| DEF 14A | — | 2023-04-27 | 2023-06-13 | |
| DEFA14A | — | 2023-04-27 | — | |
| PRE 14A | — | 2023-04-17 | 2023-06-13 | |
| 8-K | — | 2023-03-15 | — | |
| 8-K | — | 2023-03-06 | — | |
| 10-K | — | 2023-03-06 | 2022-12-31 | |
| 8-K | — | 2023-02-03 | 2023-02-02 | |
| 8-K | — | 2023-01-09 | — | |
| 8-K | — | 2022-12-02 | — | |
| 10-Q | — | 2022-11-14 | 2022-09-30 | |
| 8-K | — | 2022-11-14 | — | |
| 8-K | — | 2022-08-08 | — | |
| 10-Q | — | 2022-08-08 | 2022-06-30 | |
| 8-K | — | 2022-06-08 | 2022-06-07 | |
| 8-K | — | 2022-05-20 | — | |
| S-3 | — | 2022-05-20 | — | |
| 10-Q | — | 2022-05-10 | 2022-03-31 | |
| 8-K | — | 2022-05-10 | — | |
| DEFA14A | — | 2022-04-26 | — | |
| DEF 14A | — | 2022-04-26 | 2022-06-07 | |
| 8-K | — | 2022-03-10 | — |
Showing 51–100 of 141 filings
Key facts
CIK
1623526
CUSIP
86150R107
13F (30d)
12 filings
12 filers
Visit website
Investor relations